Total Payments
$3,932
2023 Payments
$18.22
Companies
25
Transactions
209
Medicare Patients
10,467
Medicare Billing
$401,715
Payment Breakdown by Category
Food & Beverage$3,832 (97.5%)
Education$99.99 (2.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,832 | 208 | 97.5% |
| Education | $99.99 | 1 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,138 | 90 | $0 (2021) |
| ABBVIE INC. | $509.12 | 31 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $477.53 | 17 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $185.46 | 11 | $0 (2019) |
| Amgen Inc. | $173.64 | 6 | $0 (2019) |
| PFIZER INC. | $161.86 | 9 | $0 (2023) |
| Abbott Laboratories | $158.77 | 5 | $0 (2021) |
| Astellas Pharma US Inc | $156.44 | 5 | $0 (2021) |
| Esperion Therapeutics, Inc. | $136.05 | 9 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $124.37 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $18.22 | 1 | PFIZER INC. ($18.22) |
| 2022 | $111.21 | 1 | ABBVIE INC. ($111.21) |
| 2021 | $1,489 | 84 | Novo Nordisk Inc ($435.80) |
| 2020 | $333.50 | 35 | Novo Nordisk Inc ($273.98) |
| 2019 | $1,147 | 43 | Janssen Pharmaceuticals, Inc ($439.51) |
| 2018 | $536.85 | 27 | Novo Nordisk Inc ($138.75) |
| 2017 | $296.13 | 18 | Novo Nordisk Inc ($121.62) |
All Payment Transactions
209 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/19/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/17/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $111.21 | General |
| Category: NEUROSCIENCE | ||||||
| 12/22/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $2.58 | General |
| Category: Diabetes | ||||||
| 12/17/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $0.25 | General |
| Category: Diabetes | ||||||
| 12/14/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $120.14 | General |
| Category: Diabetes | ||||||
| 12/03/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Diabetes Care | ||||||
| 12/02/2021 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $18.75 | General |
| Category: AED | ||||||
| 11/19/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $4.97 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/12/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $92.93 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $6.39 | General |
| Category: Diabetes | ||||||
| 11/01/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $0.31 | General |
| Category: Diabetes | ||||||
| 10/29/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/28/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $124.08 | General |
| Category: NEUROLOGY | ||||||
| 10/28/2021 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $16.79 | General |
| Category: AED | ||||||
| 10/28/2021 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $16.79 | General |
| Category: AED | ||||||
| 10/28/2021 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $14.77 | General |
| Category: AED | ||||||
| 10/28/2021 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $14.77 | General |
| Category: AED | ||||||
| 10/22/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Diabetes Care | ||||||
| 10/21/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $115.87 | General |
| Category: Diabetes | ||||||
| 10/13/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.34 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 10 | 470 | 472 | $13,968 | $6,323 |
| 2021 | 49 | 5,691 | 6,926 | $481,510 | $230,198 |
| 2020 | 43 | 4,306 | 5,715 | $396,125 | $165,194 |
Total Patients
10,467
Total Services
13,113
Medicare Billing
$401,715
Procedure Codes
104
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 82306 | Vitamin d-3 level | Office | 2022 | 97 | 97 | $6,305 | $2,844 | 45.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 73 | 73 | $1,679 | $758.59 | 45.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 58 | 58 | $1,682 | $758.30 | 45.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 74 | 75 | $1,275 | $578.35 | 45.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 53 | 53 | $1,113 | $511.30 | 45.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 21 | 22 | $814.00 | $366.37 | 45.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2022 | 12 | 12 | $396.00 | $179.76 | 45.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 57 | 57 | $399.00 | $179.43 | 45.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2022 | 12 | 12 | $240.00 | $107.43 | 44.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 13 | 13 | $65.00 | $38.91 | 59.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 396 | 563 | $122,976 | $47,436 | 38.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 298 | 298 | $65,560 | $40,120 | 61.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 282 | 399 | $61,390 | $25,720 | 41.9% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 691 | 691 | $41,801 | $23,308 | 55.8% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 603 | 604 | $28,984 | $16,526 | 57.0% |
| 82306 | Vitamin d-3 level | Office | 2021 | 242 | 267 | $17,355 | $7,894 | 45.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 95 | 95 | $10,348 | $6,200 | 59.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 381 | 512 | $11,776 | $5,407 | 45.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 287 | 380 | $11,020 | $5,088 | 46.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 60 | 71 | $9,553 | $4,743 | 49.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 376 | 517 | $8,789 | $4,017 | 45.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 22 | 22 | $7,238 | $3,753 | 51.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 36 | 43 | $8,428 | $3,679 | 43.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 26 | 28 | $7,392 | $3,599 | 48.7% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 15 | 15 | $6,165 | $3,598 | 58.4% |
About Dr. Christopher Webb, MD
Dr. Christopher Webb, MD is a Geriatric Medicine healthcare provider based in Lynchburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801879317.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Webb, MD has received a total of $3,932 in payments from pharmaceutical and medical device companies, with $18.22 received in 2023. These payments were reported across 209 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,832).
As a Medicare-enrolled provider, Webb has provided services to 10,467 Medicare beneficiaries, totaling 13,113 services with total Medicare billing of $401,715. Data is available for 3 years (2020–2022), covering 104 distinct procedure/service records.
Ad
Practice Information
- Specialty Geriatric Medicine
- Location Lynchburg, VA
- Active Since 11/29/2005
- Last Updated 08/30/2016
- Taxonomy Code 207RG0300X
- Entity Type Individual
- NPI Number 1801879317
Products in Payments
- Ozempic (Drug) $541.08
- UBRELVY (Drug) $369.92
- INVOKANA (Drug) $243.48
- RYBELSUS (Drug) $242.93
- XARELTO (Drug) $234.05
- APTIOM (Drug) $185.46
- ELIQUIS (Drug) $143.09
- NEXLETOL (Drug) $136.05
- Victoza (Drug) $132.68
- Tresiba (Drug) $132.12
- VRAYLAR (Drug) $131.47
- EVENITY (Biological) $131.26
- INGREZZA (Drug) $124.08
- JARDIANCE (Drug) $118.37
- BREZTRI (Drug) $106.46
- FreeStyle Libre blood glucose Flash Monitoring System (Device) $97.94
- TROKENDI XR (Drug) $81.87
- NUPLAZID (Drug) $80.22
- TOUJEO (Drug) $73.58
- MYRBETRIQ (Drug) $56.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.